Clinical trials
Completed Measles trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 10 |
| 2007 | 7 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 7 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 89 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 20 |
| Merck Sharp & Dohme LLC | 18 |
| Sanofi Pasteur, a Sanofi Company | 6 |
| The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 6 |
| Bandim Health Project | 5 |
| Centers for Disease Control and Prevention | 3 |
| Johns Hopkins Bloomberg School of Public Health | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Centers for Disease Control and Prevention, China | 2 |
| Takeda | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Measles | 89 |
| Rubella | 61 |
| Mumps | 55 |
| Chickenpox | 36 |
| Haemophilus Infections | 7 |
| Whooping Cough | 7 |
| Diphtheria | 6 |
| Tetanus | 6 |
| Hepatitis B | 5 |
| Encephalitis, Japanese | 4 |
Trials
Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.